Cargando…
Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic
Background and Objectives: The COVID-19 pandemic is an ongoing public health emergency. Patients with chronic diseases are at greater risk for complications and poor outcomes. The objective of this study was to investigate the liver function abnormalities and clinical outcomes in patients with COVID...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226804/ https://www.ncbi.nlm.nih.gov/pubmed/34200570 http://dx.doi.org/10.3390/medicina57060597 |
_version_ | 1783712374154330112 |
---|---|
author | Cerbu, Bianca Pantea, Stelian Bratosin, Felix Vidican, Iulia Turaiche, Mirela Frent, Stefan Borsi, Ema Marincu, Iosif |
author_facet | Cerbu, Bianca Pantea, Stelian Bratosin, Felix Vidican, Iulia Turaiche, Mirela Frent, Stefan Borsi, Ema Marincu, Iosif |
author_sort | Cerbu, Bianca |
collection | PubMed |
description | Background and Objectives: The COVID-19 pandemic is an ongoing public health emergency. Patients with chronic diseases are at greater risk for complications and poor outcomes. The objective of this study was to investigate the liver function abnormalities and clinical outcomes in patients with COVID-19 and chronic hepatitis C. Materials and Methods: This retrospective, single-center study was conducted on a cohort of 126 patients with a history of hepatitis C, confirmed with COVID-19 between 01 April 2020 and 30 December 2020. Several clinical outcomes were compared between patients with active and non-active HCV infection, and the risks of liver impairment and all-cause mortality in active HCV patients were analyzed using a multivariate logistic regression model. Results: Among 1057 patients under follow-up for chronic HCV infection, 126 (11.9%) were confirmed with COVID-19; of these, 95 (75.4%) were under treatment or achieved SVR, while in the other 31 (24.6%), we found active HCV replication. There was a significantly higher proportion of severe COVID-19 cases in the active HCV group as compared to the non-active HCV group (32.2 vs. 7.3%, p < 0.001). Multivariate analysis showed that age, sex, alanine aminotransferase, C-reactive protein, procalcitonin, and HCV viral load were significant independent risk factors for liver impairment and all-cause mortality. The length of stay in hospital and intensive care unit for COVID-19 was significantly higher in patients with active HCV infection (p-value < 0.001), and a higher proportion of these patients required mechanical ventilation. Conclusions: Active HCV infection is an independent risk factor for all-cause mortality in COVID-19 patients. |
format | Online Article Text |
id | pubmed-8226804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82268042021-06-26 Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic Cerbu, Bianca Pantea, Stelian Bratosin, Felix Vidican, Iulia Turaiche, Mirela Frent, Stefan Borsi, Ema Marincu, Iosif Medicina (Kaunas) Article Background and Objectives: The COVID-19 pandemic is an ongoing public health emergency. Patients with chronic diseases are at greater risk for complications and poor outcomes. The objective of this study was to investigate the liver function abnormalities and clinical outcomes in patients with COVID-19 and chronic hepatitis C. Materials and Methods: This retrospective, single-center study was conducted on a cohort of 126 patients with a history of hepatitis C, confirmed with COVID-19 between 01 April 2020 and 30 December 2020. Several clinical outcomes were compared between patients with active and non-active HCV infection, and the risks of liver impairment and all-cause mortality in active HCV patients were analyzed using a multivariate logistic regression model. Results: Among 1057 patients under follow-up for chronic HCV infection, 126 (11.9%) were confirmed with COVID-19; of these, 95 (75.4%) were under treatment or achieved SVR, while in the other 31 (24.6%), we found active HCV replication. There was a significantly higher proportion of severe COVID-19 cases in the active HCV group as compared to the non-active HCV group (32.2 vs. 7.3%, p < 0.001). Multivariate analysis showed that age, sex, alanine aminotransferase, C-reactive protein, procalcitonin, and HCV viral load were significant independent risk factors for liver impairment and all-cause mortality. The length of stay in hospital and intensive care unit for COVID-19 was significantly higher in patients with active HCV infection (p-value < 0.001), and a higher proportion of these patients required mechanical ventilation. Conclusions: Active HCV infection is an independent risk factor for all-cause mortality in COVID-19 patients. MDPI 2021-06-10 /pmc/articles/PMC8226804/ /pubmed/34200570 http://dx.doi.org/10.3390/medicina57060597 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cerbu, Bianca Pantea, Stelian Bratosin, Felix Vidican, Iulia Turaiche, Mirela Frent, Stefan Borsi, Ema Marincu, Iosif Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic |
title | Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic |
title_full | Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic |
title_fullStr | Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic |
title_full_unstemmed | Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic |
title_short | Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic |
title_sort | liver impairment and hematological changes in patients with chronic hepatitis c and covid-19: a retrospective study after one year of pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226804/ https://www.ncbi.nlm.nih.gov/pubmed/34200570 http://dx.doi.org/10.3390/medicina57060597 |
work_keys_str_mv | AT cerbubianca liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT panteastelian liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT bratosinfelix liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT vidicaniulia liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT turaichemirela liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT frentstefan liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT borsiema liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic AT marincuiosif liverimpairmentandhematologicalchangesinpatientswithchronichepatitiscandcovid19aretrospectivestudyafteroneyearofpandemic |